Panel: How Labcorp is investing in the future of healthcare by supporting a wide range of innovative solutions

Health and physician system leaders are facing unprecedented challenges while operating in an ever-evolving healthcare landscape. In support of Labcorp’s mission to improve health and improve lives, the Labcorp Venture Fund invests in early-stage private companies operating in strategic or adjacent spaces developing novel solutions to important problems in health and healthcare.

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 12, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2023 , to stockholders of record as

Tom Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit

Mr. Pike Brings 30 Years of Industry Experience and a Proven Track Record of Driving Growth 

Labcorp to speak at the 41st annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m.